152 related articles for article (PubMed ID: 34405250)
1. The Diversity of Vaginal Microbiota Predicts Neoadjuvant Chemotherapy Responsiveness in Locally Advanced Cervical Cancer.
Wang Z; Xiao R; Huang J; Qin X; Hu D; Guo E; Liu C; Lu F; You L; Sun C; Chen G
Microb Ecol; 2022 Jul; 84(1):302-313. PubMed ID: 34405250
[TBL] [Abstract][Full Text] [Related]
2. Relationship between vaginal and oral microbiome in patients of human papillomavirus (HPV) infection and cervical cancer.
Zhang W; Yin Y; Jiang Y; Yang Y; Wang W; Wang X; Ge Y; Liu B; Yao L
J Transl Med; 2024 Apr; 22(1):396. PubMed ID: 38685022
[TBL] [Abstract][Full Text] [Related]
3. [Primary study on the relationship between high-risk HPV infection and vaginal cervical microbiota].
Zhang Z; Zhang D; Xiao BB; Zhang R; Bai HH; Dong HY; Bi H; Liu ZH
Zhonghua Fu Chan Ke Za Zhi; 2018 Jul; 53(7):471-480. PubMed ID: 30078257
[No Abstract] [Full Text] [Related]
4. Exploring the diversity of vaginal microbiota between healthy women and cervical cancer patients in India.
Kamble A; Naik S; Talathi M; Jadhav D; Sakharkar M; Yang J; Prakash O; Kaul-Ghanekar R
J Med Microbiol; 2024 Mar; 73(3):. PubMed ID: 38546452
[No Abstract] [Full Text] [Related]
5. Leveraging existing 16S rRNA gene surveys to decipher microbial signatures and dysbiosis in cervical carcinogenesis.
Li X; Xiang F; Liu T; Chen Z; Zhang M; Li J; Kang X; Wu R
Sci Rep; 2024 May; 14(1):11532. PubMed ID: 38773342
[TBL] [Abstract][Full Text] [Related]
6. Distinction between vaginal and cervical microbiota in high-risk human papilloma virus-infected women in China.
Zhang Z; Li T; Zhang D; Zong X; Bai H; Bi H; Liu Z
BMC Microbiol; 2021 Mar; 21(1):90. PubMed ID: 33765914
[TBL] [Abstract][Full Text] [Related]
7. Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls.
Sims TT; Colbert LE; Zheng J; Delgado Medrano AY; Hoffman KL; Ramondetta L; Jazaeri A; Jhingran A; Schmeler KM; Daniel CR; Klopp A
Gynecol Oncol; 2019 Nov; 155(2):237-244. PubMed ID: 31500892
[TBL] [Abstract][Full Text] [Related]
8. Changes in vaginal microbiome after focused ultrasound treatment of high-risk human papillomavirus infection-related low-grade cervical lesions.
Wang W; Liu Y; Yang Y; Ren J; Zhou H
BMC Infect Dis; 2023 Jan; 23(1):3. PubMed ID: 36604622
[TBL] [Abstract][Full Text] [Related]
9. Vaginal microecological changes of different degrees of cervical lesions in Hakka women in Meizhou City.
Zeng W; Liang Y; Zhou J; Lin H; Huang L; He D; Wen J; Wu B; Liu H; Zhong Y; Lei N; Yang H
J Obstet Gynaecol; 2023 Dec; 43(1):2186780. PubMed ID: 36939019
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Association Between Cervical Microbiota and HR-HPV Infection Based on 16S rRNA Gene and Metagenomic Sequencing.
Fang B; Li Q; Wan Z; OuYang Z; Zhang Q
Front Cell Infect Microbiol; 2022; 12():922554. PubMed ID: 35800388
[TBL] [Abstract][Full Text] [Related]
11. Leveraging 16S rRNA data to uncover vaginal microbial signatures in women with cervical cancer.
Wu M; Yu H; Gao Y; Li H; Wang C; Li H; Ma X; Dong M; Li B; Bai J; Dong Y; Fan X; Zhang J; Yan Y; Qi W; Han C; Fan A; Xue F
Front Cell Infect Microbiol; 2023; 13():1024723. PubMed ID: 36743303
[TBL] [Abstract][Full Text] [Related]
12. The feature of cervical microbiota associated with the progression of cervical cancer among reproductive females.
Wu S; Ding X; Kong Y; Acharya S; Wu H; Huang C; Liang Y; Nong X; Chen H
Gynecol Oncol; 2021 Nov; 163(2):348-357. PubMed ID: 34503848
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of vaginal microbiota sampling using 16S rRNA gene analysis.
Virtanen S; Kalliala I; Nieminen P; Salonen A
PLoS One; 2017; 12(7):e0181477. PubMed ID: 28723942
[TBL] [Abstract][Full Text] [Related]
14. Distribution of Vaginal and Gut Microbiome in Advanced Maternal Age.
Huang Y; Li D; Cai W; Zhu H; Shane MI; Liao C; Pan S
Front Cell Infect Microbiol; 2022; 12():819802. PubMed ID: 35694547
[TBL] [Abstract][Full Text] [Related]
15. Comparison of different hypervariable regions of 16S rRNA for taxonomic profiling of vaginal microbiota using next-generation sequencing.
Sirichoat A; Sankuntaw N; Engchanil C; Buppasiri P; Faksri K; Namwat W; Chantratita W; Lulitanond V
Arch Microbiol; 2021 Apr; 203(3):1159-1166. PubMed ID: 33221964
[TBL] [Abstract][Full Text] [Related]
16. Patients With LR-HPV Infection Have a Distinct Vaginal Microbiota in Comparison With Healthy Controls.
Zhou Y; Wang L; Pei F; Ji M; Zhang F; Sun Y; Zhao Q; Hong Y; Wang X; Tian J; Wang Y
Front Cell Infect Microbiol; 2019; 9():294. PubMed ID: 31555603
[TBL] [Abstract][Full Text] [Related]
17. Vaginal Dysbiotic Microbiome in Women With No Symptoms of Genital Infections.
Pramanick R; Nathani N; Warke H; Mayadeo N; Aranha C
Front Cell Infect Microbiol; 2021; 11():760459. PubMed ID: 35096634
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the vaginal and endometrial microbiome in patients with chronic endometritis.
Lozano FM; Bernabeu A; Lledo B; Morales R; Diaz M; Aranda FI; Llacer J; Bernabeu R
Eur J Obstet Gynecol Reprod Biol; 2021 Aug; 263():25-32. PubMed ID: 34144490
[TBL] [Abstract][Full Text] [Related]
19. The Value of Vaginal Microbiome in Patients with Endometrial Hyperplasia.
Zhang H; Feng Q; Zhu Z; Dai H; Hu H
J Healthc Eng; 2021; 2021():4289931. PubMed ID: 34961826
[TBL] [Abstract][Full Text] [Related]
20. The Role of 2D/3D Ultrasound to Assess the Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer.
Perniola G; Tomao F; Graziano M; Palaia I; Fischetti M; Lecce F; Casorelli A; Di Donato V; Giancotti A; Battaglia FA; Muzii L; Benedetti Panici P
Oncology; 2020; 98(11):807-813. PubMed ID: 32892198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
